SCHEMBL5833660

SCHEMBL5833660

O=C1CCCC2=C1CCCCC2

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.38
TRIM24 O15164 2/20 0.38
TRIM33 Q9UPN9 2/20 0.38
MAOA P21397 2/20 0.34
MAOB P27338 2/20 0.34
CYP2A6 P11509 1/20 0.34
PLK1 P53350 1/20 0.33
CSNK2A1 P68400 1/20 0.33
PLK3 Q9H4B4 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
HSD17B10 Q99714 2/20 0.32
HPGD P15428 2/20 0.32
HTT P42858 1/20 0.32
MEN1 O00255 2/20 0.30
KMT2A Q03164 2/20 0.30
PRKCI P41743 1/20 0.30
MAPK1 P28482 1/20 0.30
NPSR1 Q6W5P4 1/20 0.30
MAPT P10636 1/20 0.30
ALOX15 P16050 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8900690 1.00 ALDH1A1 (0.38) ALDH1A1TRIM24TRIM33MAOAMAOB
SCHEMBL6151244 1.00 ALDH1A1 (0.38) ALDH1A1TRIM24TRIM33MAOAMAOB
SCHEMBL131908 0.97 ALDH1A1 (0.40) ALDH1A1TRIM24TRIM33MAOAMAOB
SCHEMBL5464779 0.97 TRIM24 (0.35) ALDH1A1TRIM24TRIM33MAOAMAOB
SCHEMBL5626714 0.94 ALDH1A1 (0.33) ALDH1A1TRIM24TRIM33MAOAMAOB
SCHEMBL6249725 0.94 TRIM24 (0.37) ALDH1A1TRIM24TRIM33SMN1; SMN2HSD17B10
SCHEMBL8350165 0.89 TRIM24 (0.38) ALDH1A1TRIM24TRIM33HSD17B10HPGD
SCHEMBL8070883 0.89 TRIM24 (0.38) ALDH1A1TRIM24TRIM33HSD17B10HPGD
SCHEMBL29540851 0.89 TRIM24 (0.38) ALDH1A1TRIM24TRIM33HSD17B10HPGD
SCHEMBL889421 0.86 TRIM24 (0.35) ALDH1A1TRIM24TRIM33HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7012078-B2 2-aminopyridines containing fused ring substituents PFIZER INC. (US) 2006-03-14 US disclosed
EP-1007520-B1 2-AMINOPYRIDINES CONTAINING FUSED RING SUBSTITUENTS AS NOS INHIBITORS PFIZER PROD INC (US) 2003-08-27 EP disclosed
US-20030149017-A1 2-Aminopyridines containing fused ring substituents PFIZER INC. 2003-08-07 US disclosed
US-20010049379-A1 2-aminopyridines containing fused ring substituents LOWE JOHN ADAMS (US) 2001-12-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030149017-A1 2-Aminopyridines containing fused ring substituents NOS2, NOS1, NOS3 ALDH1A1 325/4885TRIM24 4430/4885TRIM33 3821/4885
US-20010049379-A1 2-aminopyridines containing fused ring substituents NOS2, NOS1, NOS3 ALDH1A1 325/4885TRIM24 4430/4885TRIM33 3821/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.